Artivion (AORT) Revenue & Revenue Breakdown

Overview ForecastFinancials Chart Transcripts

Artivion Revenue Highlights

Latest Revenue (Y)

$354.00M

Latest Revenue (Q)

$95.78M

Main Segment (Y)

Products

Main Geography (Y)

UNITED STATES

Artivion Revenue by Period

Artivion Revenue by Year

Date	Revenue	Change
2023-12-31	$354.00M	12.82%
2022-12-31	$313.79M	5.00%
2021-12-31	$298.84M	18.01%
2020-12-31	$253.23M	-8.32%
2019-12-31	$276.22M	5.09%
2018-12-31	$262.84M	38.55%
2017-12-31	$189.70M	5.17%
2016-12-31	$180.38M	23.63%
2015-12-31	$145.90M	0.87%
2014-12-31	$144.64M	2.75%
2013-12-31	$140.76M	6.87%
2012-12-31	$131.72M	10.11%
2011-12-31	$119.63M	2.56%
2010-12-31	$116.64M	4.44%
2009-12-31	$111.69M	6.31%
2008-12-31	$105.06M	10.87%
2007-12-31	$94.76M	16.54%
2006-12-31	$81.31M	17.36%
2005-12-31	$69.28M	11.06%
2004-12-31	$62.38M	4.79%
2003-12-31	$59.53M	-23.48%
2002-12-31	$77.80M	-11.26%
2001-12-31	$87.67M	13.72%
2000-12-31	$77.10M	15.55%
1999-12-31	$66.72M	9.92%
1998-12-31	$60.70M	19.25%
1997-12-31	$50.90M	37.57%
1996-12-31	$37.00M	27.59%
1995-12-31	$29.00M	22.88%
1994-12-31	$23.60M	11.32%
1993-12-31	$21.20M	-

Artivion generated $354.00M in revenue during NA 2023, up 12.82% compared to the previous quarter, and up 134.68% compared to the same period a year ago.

Artivion Revenue by Quarter

Date	Revenue	Change
2024-09-30	$95.78M	-2.29%
2024-06-30	$98.02M	0.60%
2024-03-31	$97.43M	4.02%
2023-12-31	$93.67M	6.62%
2023-09-30	$87.85M	-1.57%
2023-06-30	$89.25M	7.24%
2023-03-31	$83.23M	4.83%
2022-12-31	$79.40M	3.33%
2022-09-30	$76.84M	-4.36%
2022-06-30	$80.34M	4.05%
2022-03-31	$77.21M	-2.75%
2021-12-31	$79.39M	9.95%
2021-09-30	$72.21M	-5.18%
2021-06-30	$76.15M	7.12%
2021-03-31	$71.09M	4.70%
2020-12-31	$67.90M	4.25%
2020-09-30	$65.13M	21.13%
2020-06-30	$53.77M	-19.05%
2020-03-31	$66.43M	-4.69%
2019-12-31	$69.70M	2.68%
2019-09-30	$67.88M	-4.58%
2019-06-30	$71.14M	5.38%
2019-03-31	$67.50M	-0.43%
2018-12-31	$67.80M	4.96%
2018-09-30	$64.60M	-5.69%
2018-06-30	$68.50M	10.57%
2018-03-31	$61.95M	17.27%
2017-12-31	$52.83M	20.06%
2017-09-30	$44.00M	-7.99%
2017-06-30	$47.82M	6.12%
2017-03-31	$45.06M	0.07%
2016-12-31	$45.03M	-0.49%
2016-09-30	$45.25M	-3.89%
2016-06-30	$47.08M	9.45%
2016-03-31	$43.02M	7.98%
2015-12-31	$39.84M	8.54%
2015-09-30	$36.70M	3.31%
2015-06-30	$35.53M	5.01%
2015-03-31	$33.83M	-8.94%
2014-12-31	$37.15M	0.22%
2014-09-30	$37.07M	6.86%
2014-06-30	$34.69M	-2.91%
2014-03-31	$35.73M	0.77%
2013-12-31	$35.46M	-2.19%
2013-09-30	$36.25M	8.14%
2013-06-30	$33.52M	-5.67%
2013-03-31	$35.54M	8.34%
2012-12-31	$32.80M	-1.88%
2012-09-30	$33.43M	0.73%
2012-06-30	$33.19M	2.75%
2012-03-31	$32.30M	6.26%
2011-12-31	$30.40M	2.51%
2011-09-30	$29.65M	0.94%
2011-06-30	$29.38M	-2.71%
2011-03-31	$30.20M	3.33%
2010-12-31	$29.22M	2.74%
2010-09-30	$28.44M	-2.80%
2010-06-30	$29.26M	-1.53%
2010-03-31	$29.72M	3.85%
2009-12-31	$28.61M	1.40%
2009-09-30	$28.22M	0.20%
2009-06-30	$28.16M	5.53%
2009-03-31	$26.69M	4.53%
2008-12-31	$25.53M	-4.75%
2008-09-30	$26.80M	-1.29%
2008-06-30	$27.16M	6.21%
2008-03-31	$25.57M	1.99%
2007-12-31	$25.07M	-

Artivion generated $95.78M in revenue during Q3 2024, up -2.29% compared to the previous quarter, and up 107.31% compared to the same period a year ago.

Artivion Revenue Breakdown

Artivion Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Products	$261.19M	$230.35M	$221.60M	$179.30M	-
Other Products	$11.17M	$8.32M	$8.13M	-	-
On X	$74.53M	$63.90M	$57.36M	$48.05M	$50.10M
Aortic Stent Grafts	$107.47M	-	-	-	-
Surgical Sealants	$68.02M	$65.38M	$70.71M	-	-
Aortic Stents And Stent Grafts	-	$92.75M	$85.39M	$61.66M	-
Preservation Services	-	$83.44M	$77.24M	$73.93M	$78.98M
Bioglue	-	-	-	$62.07M	$68.61M
Cardiac Tissue	-	-	-	$37.89M	$40.88M
Cardiogenesis Cardiac Laser Therapy	-	-	-	$464.00K	$6.02M
Neopatch	-	-	-	$183.00K	-
Per Clot	-	-	-	$2.88M	$3.79M
Photofix	-	-	-	$4.17M	$3.75M
Vascular Tissue	-	-	-	$35.85M	$38.10M
Jotec Ag	-	-	-	-	$64.97M

Artivion's latest annual revenue breakdown by segment (product or service), as of Dec 23: Products (50.00%), Aortic Stent Grafts (20.57%), On X (14.27%), Surgical Sealants (13.02%), and Other Products (2.14%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
Aortic Stent Grafts	$28.64M	$32.10M	$27.44M	$25.52M	$28.36M	$26.15M	$19.67M	$23.83M	$25.51M	-	-	-	-	-	-	-	-	-	-	-
Surgical Sealants	$18.44M	$16.98M	$18.51M	$16.23M	$16.57M	$16.70M	$17.37M	$15.97M	$15.68M	$16.54M	$17.86M	$17.83M	-	-	-	-	-	-	-	-
Products	$71.24M	$71.11M	$69.14M	$63.75M	$66.00M	$62.29M	$55.25M	$58.94M	$57.54M	$53.11M	$56.08M	$53.34M	$50.50M	-	-	-	-	-	-	-
Other Products	$2.69M	$2.35M	$3.01M	$3.25M	$3.13M	$1.78M	$1.74M	$2.88M	$1.98M	$1.65M	$2.42M	$2.22M	-	-	-	-	-	-	-	-
On X	$21.48M	$19.68M	$20.18M	$18.74M	$17.95M	$17.66M	$16.46M	$16.25M	$14.37M	$14.02M	$14.73M	$13.10M	$13.67M	$12.07M	$10.12M	$12.20M	$13.35M	$12.61M	$12.41M	-
International Hospitals	-	-	-	-	-	-	$25.30M	-	-	-	-	-	-	-	-	-	-	-	-	-
Cardiogenesis	-	-	-	-	-	-	$389.00K	-	-	-	-	-	-	-	-	-	-	-	-	-
Domestic Hospitals	-	-	-	-	-	-	$40.79M	-	-	-	-	-	-	-	-	-	-	-	-	-
International Distributor	-	-	-	-	-	-	$12.92M	-	-	-	-	-	-	-	-	-	-	-	-	-
Aortic Stents And Stent Grafts	-	-	-	-	-	-	-	-	-	-	$20.90M	$21.06M	$20.20M	-	-	-	-	-	-	-
Vascular Tissue	-	-	-	-	-	-	-	-	-	-	-	-	-	$8.20M	$9.29M	$9.98M	$9.36M	$9.09M	$9.47M	-
Bioglue	-	-	-	-	-	-	-	-	-	-	-	-	-	$17.08M	$15.81M	$12.44M	$16.74M	-	-	-
Cardiac Tissue	-	-	-	-	-	-	-	-	-	-	-	-	-	$9.13M	$10.68M	$8.06M	$10.03M	$10.14M	$11.30M	$10.50M
Cardiogenesis Cardiac Laser Therapy	-	-	-	-	-	-	-	-	-	-	-	-	-	$106.00K	$83.00K	$164.00K	$111.00K	$1.05M	$1.35M	$1.90M
Neopatch	-	-	-	-	-	-	-	-	-	-	-	-	-	$64.00K	$58.00K	-	-	-	-	-
Per Clot	-	-	-	-	-	-	-	-	-	-	-	-	-	$801.00K	$724.00K	$497.00K	$860.00K	$981.00K	$980.00K	$784.00K
Photofix	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.11M	$1.13M	$880.00K	$1.04M	$1.00M	$1.09M	$935.00K
Preservation Services	-	-	-	-	-	-	-	-	-	-	-	-	-	$17.39M	-	-	-	-	-	-
Jotec Ag	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$15.29M	$13.17M	$15.27M	$16.04M	$15.77M	$17.21M
Nexus	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$200.00K	-	-	-
Bio Glue And Bio Foam	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$15.68M	$17.93M

Artivion's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Products (50.00%), Aortic Stent Grafts (20.10%), On X (15.07%), Surgical Sealants (12.94%), and Other Products (1.89%).

Artivion Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
UNITED STATES	$179.49M	$161.11M	-	-	-
Non-US	$174.52M	$152.68M	-	-	-
U	-	-	$151.15M	$138.27M	$150.55M
Non Us	-	-	$147.69M	$114.95M	$125.67M

Artivion's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (50.70%), and Non-US (49.30%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24
Asia Pacific Segment	$10.37M	$7.61M
North America Segment	$49.09M	$50.93M
Europe, the Middle East, and Africa Segments	$30.42M	$33.59M
Latin America Segment	$5.90M	$5.31M

Artivion's latest quarterly revenue breakdown by geography, as of Sep 24: North America Segment (51.25%), Europe, the Middle East, and Africa Segments (31.76%), Asia Pacific Segment (10.82%), and Latin America Segment (6.16%).

Artivion Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ITGR	Integer	$1.60B	$746.27M
CNMD	CONMED	$1.24B	$316.70M
AVNS	Avanos Medical	$673.30M	$170.40M
AORT	Artivion	$354.00M	$95.78M
ANIK	Anika Therapeutics	$166.66M	$38.75M
ESTA	Establishment Labs	$165.15M	$40.23M
AXGN	AxoGen	$159.01M	$48.64M
KIDS	OrthoPediatrics	$148.73M	$52.80M
SIBN	SI-BONE	$138.89M	$40.34M
SRDX	Surmodics	$126.08M	$30.34M
SGHT	Sight Sciences	$81.06M	$20.16M
LUNG	Pulmonx	$68.67M	$20.39M
NPCE	NeuroPace	$65.42M	$21.06M
CVRX	CVRx	$39.30M	$13.37M
OFIX	Orthofix Medical	$100.00K	$198.62M

AORT Revenue FAQ

What is Artivion’s yearly revenue?

Artivion's yearly revenue for 2023 was $354M, representing an increase of 12.82% compared to 2022. The company's yearly revenue for 2022 was $313.79M, representing an increase of 5.00% compared to 2021. AORT's yearly revenue for 2021 was $298.84M, representing an increase of 18.01% compared to 2020.

What is Artivion’s quarterly revenue?

Artivion's quarterly revenue for Q3 2024 was $95.78M, a -2.29% decrease from the previous quarter (Q2 2024), and a 9.02% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $98.02M, a 0.60% increase from the previous quarter (Q1 2024), and a 9.82% increase year-over-year (Q2 2023). AORT's quarterly revenue for Q1 2024 was $97.43M, a 4.02% increase from the previous quarter (Q4 2023), and a 17.06% increase year-over-year (Q1 2023).

What is Artivion’s revenue growth rate?

Artivion's revenue growth rate for the last 3 years (2021-2023) was 18.46%, and for the last 5 years (2019-2023) was 28.16%.

What are Artivion’s revenue streams?

Artivion's revenue streams in c 23 are Products, Other Products, On X, Aortic Stent Grafts, and Surgical Sealants. Products generated $261.18M in revenue, accounting 50.00% of the company's total revenue, up 13.38% year-over-year. Other Products generated $11.17M in revenue, accounting 2.14% of the company's total revenue, up 34.31% year-over-year. On X generated $74.53M in revenue, accounting 14.27% of the company's total revenue, up 16.62% year-over-year. Aortic Stent Grafts generated $107.47M in revenue, accounting 20.57% of the company's total revenue Surgical Sealants generated $68.02M in revenue, accounting 13.02% of the company's total revenue, up 4.03% year-over-year.

What is Artivion’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Artivion was Products. This segment made a revenue of $261.18M, representing 50.00% of the company's total revenue.